Clinical Trial Update: A Study of Oraxol® in Gastric Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on Oraxol (oral paclitaxel) for gastric cancer, conducted in Phase 1 and Phase 2, sponsored by Hanmi Pharmaceutical Company Limited; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Oraxol

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Advanced Metastatic Gastric Cancer, Recurrent Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN